17 results on '"Mathiasen, Anders B."'
Search Results
2. Bone marrow‐derived mesenchymal stromal cell treatment in patients with ischaemic heart failure: final 4‐year follow‐up of the MSC‐HF trial
3. Erratum to “Overcoming the bottleneck of platelet lysate supply in large-scale clinical expansion of adipose-derived stem cells: A comparison of fresh versus three types of platelet lysates from outdated buffy coat–derived platelet concentrates” [Cytotherapy 2017;19:222–234]
4. Overcoming the bottleneck of platelet lysate supply in large-scale clinical expansion of adipose-derived stem cells: A comparison of fresh versus three types of platelet lysates from outdated buffy coat–derived platelet concentrates
5. Quantification of myocardial perfusion using cardiac magnetic resonance imaging correlates significantly to rubidium-82 positron emission tomography in patients with severe coronary artery disease: A preliminary study
6. Ultrastructural characterization of mesenchymal stromal cells labeled with ultrasmall superparamagnetic iron-oxide nanoparticles for clinical tracking studies
7. Value of cardiac 320-multidetector computed tomography and cardiac magnetic resonance imaging for assessment of myocardial perfusion defects in patients with known chronic ischemic heart disease
8. Direct Intramyocardial Mesenchymal Stromal Cell Injections in Patients with Severe Refractory Angina: One-Year Follow-Up
9. Angiographic Features and Cardiovascular Risk Factors in Human Immunodeficiency Virus-Infected Patients With First-Time Acute Coronary Syndrome
10. Myocardial area at risk after ST-elevation myocardial infarction measured with the late gadolinium enhancement after scar remodeling and T2-weighted cardiac magnetic resonance imaging
11. Myocardial area at risk and salvage measured by T2-weighted cardiovascular magnetic resonance: Reproducibility and comparison of two T2-weighted protocols
12. Plasma YKL-40 in relation to the degree of coronary artery disease in patients with stable ischemic heart disease
13. Mesenchymal stromal cell derived endothelial progenitor treatment in patients with refractory angina
14. MESENCHYMAL STEM CELLS THERAPY IN PATIENTS WITH CHRONIC CORONARY ARTERY DISEASE: 12 MONTHS FOLLOW-UP
15. MYOCARDIUM AREA AT RISK MEASURED WITH DELAYED ENHANCEMENT AFTER SCAR REMODELING COMPARED WITH T2-WEIGHTED CARDIAC MAGNETIC RESONANCE IMAGING
16. PLASMA YKL-40 IN RELATION TO THE DEGREE OF CORONARY ARTERY DISEASE IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE
17. Myocardium area at risk measured with delayed enhancement after scar remodelling compared with T2-weighted cardiac magnetic resonance imaging
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.